Trending:

November 7, 2025, 04:25 PM - 2 min read
Mumbai-based drug-maker, Lupin, reported an increase in its consolidated profit after tax to ₹1,485 crore in the September quarter, led by growth in US and emerging markets
Read more
August 12, 2025, 02:21 PM - 2 min read
Mumbai-based drug-maker firm, Lupin, has partnered with Switzerland-based Sandoz Group AG to commercialise the biosimilar drug, ranibizumab, across the EU, Hong Kong, Vietnam, Australia, Norway, Switzerland, and Canada
Read more